TRxADE HEALTH, Inc. (MEDS)
USD 7.59
(4.55%)
USD 7.59
(4.55%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 8.27 Million USD | -27.74% |
| 2022 | 11.44 Million USD | 15.76% |
| 2021 | 9.88 Million USD | -42.24% |
| 2020 | 17.12 Million USD | 130.26% |
| 2019 | 7.43 Million USD | 94.07% |
| 2018 | 3.83 Million USD | 30.72% |
| 2017 | 2.93 Million USD | 18.11% |
| 2016 | 2.48 Million USD | -50.29% |
| 2015 | 4.99 Million USD | 233.65% |
| 2014 | 1.49 Million USD | 56.53% |
| 2013 | 955.88 Thousand USD | 18.59% |
| 2012 | 806.04 Thousand USD | 0.0% |
| 2008 | - USD | 0.0% |
| 2007 | - USD | 0.0% |
| 2006 | - USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | - USD | -100.0% |
| 2024 Q2 | 18.69 Thousand USD | 0.0% |
| 2023 Q4 | 2.35 Million USD | 14.3% |
| 2023 FY | 8.27 Million USD | -27.74% |
| 2023 Q1 | 2.24 Million USD | -11.12% |
| 2023 Q2 | 2.25 Million USD | 0.15% |
| 2023 Q3 | 2.05 Million USD | -8.58% |
| 2022 FY | 11.44 Million USD | 15.76% |
| 2022 Q4 | 2.52 Million USD | 5.36% |
| 2022 Q2 | 3.27 Million USD | 1.19% |
| 2022 Q3 | 2.4 Million USD | -26.79% |
| 2022 Q1 | 3.24 Million USD | 35.7% |
| 2021 Q3 | 2.55 Million USD | 34.34% |
| 2021 FY | 9.88 Million USD | -42.24% |
| 2021 Q4 | 2.38 Million USD | -6.36% |
| 2021 Q1 | 3.05 Million USD | 53.1% |
| 2021 Q2 | 1.89 Million USD | -37.83% |
| 2020 Q4 | 1.99 Million USD | -68.51% |
| 2020 Q2 | 6.59 Million USD | 199.21% |
| 2020 Q1 | 2.2 Million USD | 29.92% |
| 2020 Q3 | 6.33 Million USD | -3.95% |
| 2020 FY | 17.12 Million USD | 130.26% |
| 2019 FY | 7.43 Million USD | 94.07% |
| 2019 Q4 | 1.69 Million USD | -26.63% |
| 2019 Q2 | 1.91 Million USD | 26.7% |
| 2019 Q1 | 1.51 Million USD | 16.91% |
| 2019 Q3 | 2.31 Million USD | 20.61% |
| 2018 Q2 | 837.68 Thousand USD | -1.79% |
| 2018 Q1 | 852.92 Thousand USD | 8.0% |
| 2018 Q4 | 1.29 Million USD | 52.65% |
| 2018 Q3 | 847.47 Thousand USD | 1.17% |
| 2018 FY | 3.83 Million USD | 30.72% |
| 2017 Q3 | 735.86 Thousand USD | 4.42% |
| 2017 FY | 2.93 Million USD | 18.11% |
| 2017 Q4 | 789.74 Thousand USD | 7.32% |
| 2017 Q2 | 704.72 Thousand USD | -5.53% |
| 2017 Q1 | 745.94 Thousand USD | 140.16% |
| 2016 Q2 | 1.68 Million USD | -8.56% |
| 2016 FY | 2.48 Million USD | -50.29% |
| 2016 Q3 | 803.27 Thousand USD | -52.44% |
| 2016 Q1 | 1.84 Million USD | 23.89% |
| 2016 Q4 | -1.85 Million USD | -331.25% |
| 2015 Q3 | 1.63 Million USD | 40.33% |
| 2015 FY | 4.99 Million USD | 233.65% |
| 2015 Q1 | 696.13 Thousand USD | 17.66% |
| 2015 Q2 | 1.16 Million USD | 67.67% |
| 2015 Q4 | 1.49 Million USD | -8.97% |
| 2014 Q2 | 287.71 Thousand USD | 17.82% |
| 2014 Q3 | 372.69 Thousand USD | 29.53% |
| 2014 Q1 | 244.19 Thousand USD | 21.1% |
| 2014 Q4 | 591.62 Thousand USD | 58.74% |
| 2014 FY | 1.49 Million USD | 56.53% |
| 2013 FY | 955.88 Thousand USD | 18.59% |
| 2013 Q3 | 323.4 Thousand USD | 27.01% |
| 2013 Q1 | 176.19 Thousand USD | 0.0% |
| 2013 Q2 | 254.62 Thousand USD | 44.51% |
| 2013 Q4 | 201.65 Thousand USD | -37.65% |
| 2012 FY | 806.04 Thousand USD | 0.0% |
| 2009 Q3 | - USD | 0.0% |
| 2009 Q1 | - USD | 0.0% |
| 2009 Q2 | - USD | 0.0% |
| 2008 Q4 | - USD | 0.0% |
| 2008 Q2 | - USD | 0.0% |
| 2008 Q1 | - USD | 0.0% |
| 2008 FY | - USD | 0.0% |
| 2008 Q3 | - USD | 0.0% |
| 2007 Q3 | - USD | 0.0% |
| 2007 Q2 | - USD | 0.0% |
| 2007 Q1 | - USD | 0.0% |
| 2007 FY | - USD | 0.0% |
| 2007 Q4 | - USD | 0.0% |
| 2006 Q3 | - USD | 0.0% |
| 2006 FY | - USD | 0.0% |
| 2006 Q4 | - USD | 0.0% |
| 2006 Q2 | - USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| CannBioRx Life Sciences Corp. | - USD | -Infinity% |
| BIMI International Medical Inc. | 11.83 Million USD | 30.077% |
| China Jo-Jo Drugstores, Inc. | 154.54 Million USD | 94.647% |
| Harrow Health, Inc. 8.625% Senior Notes due 2026 | 130.19 Million USD | 93.646% |
| Harrow Health, Inc. 11.875% Senior Notes due 2027 | 130.19 Million USD | 93.646% |
| Leafly Holdings, Inc. | 42.25 Million USD | 80.422% |
| Leafly Holdings, Inc. | 42.25 Million USD | 80.422% |
| LifeMD, Inc. | 152.54 Million USD | 94.577% |
| LifeMD, Inc. | 152.54 Million USD | 94.577% |
| PetMed Express, Inc. | 281.06 Million USD | 97.057% |
| Walgreens Boots Alliance, Inc. | 147.65 Billion USD | 99.994% |